Multicriteria decision analysis to support health technology assessment agencies: benefits, limitations, and the way forward R Baltussen, K Marsh, P Thokala, V Diaby, H Castro, I Cleemput, M Garau, ... Value in Health 22 (11), 1283-1288, 2019 | 149 | 2019 |
Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe A Angelis, P Kanavos, J López-Bastida, R Linertová, J Oliva-Moreno, ... The European Journal of Health Economics 17, 31-42, 2016 | 86 | 2016 |
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe M Cavazza, Y Kodra, P Armeni, M De Santis, J López-Bastida, ... The European Journal of Health Economics 17, 19-29, 2016 | 84 | 2016 |
Social/economic costs and quality of life in patients with haemophilia in Europe M Cavazza, Y Kodra, P Armeni, M De Santis, J López-Bastida, ... The European Journal of Health Economics, 1-13, 2016 | 79 | 2016 |
Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe A Kuhlmann, T Schmidt, M Treskova, J Lopez-Bastida, R Linertova, ... The European Journal of Health Economics 17, 79-87, 2016 | 68 | 2016 |
Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe K Chevreul, M Michel, KB Brigham, J López-Bastida, R Linertová, ... The European Journal of Health Economics 17, 7-18, 2016 | 65 | 2016 |
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe M Péntek, L Gulácsi, V Brodszky, P Baji, I Boncz, G Pogány, ... The European Journal of Health Economics, 1-10, 2016 | 58 | 2016 |
National registries of rare diseases in Europe: an overview of the current situation and experiences D Taruscio, L Vittozzi, R Choquet, K Heimdal, G Iskrov, Y Kodra, ... Public health genomics 18 (1), 20-25, 2015 | 56 | 2015 |
Multi-criteria decision analysis for assessment and appraisal of orphan drugs G Iskrov, T Miteva-Katrandzhieva, R Stefanov Frontiers in Public Health 4, 214, 2016 | 51 | 2016 |
Тhe economic burden and health-related quality of life associated with systemic sclerosis in France K Chevreul, K Berg Brigham, C Gandré, L Mouthon, BRDR Network Scand J Rheumatol 44 (3), 328-46, 2015 | 50 | 2015 |
Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe K Chevreul, C Gandré, KB Brigham, J López-Bastida, R Linertová, ... The European Journal of Health Economics, 1-10, 2016 | 47 | 2016 |
Challenges to orphan drugs access in Eastern Europe: The case of Bulgaria G Iskrov, T Miteva-Katrandzhieva, R Stefanov Health Policy 108 (1), 10-18, 2012 | 45 | 2012 |
Social/economic costs and health-related quality of life in patients with scleroderma in Europe J López-Bastida, R Linertová, J Oliva-Moreno, P Serrano-Aguilar, ... The European Journal of Health Economics 17, 109-117, 2016 | 42 | 2016 |
Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe J López-Bastida, R Linertová, J Oliva-Moreno, M Posada-de-la-Paz, ... The European Journal of Health Economics, 1-10, 2016 | 39 | 2016 |
General knowledge and awareness on rare diseases among general practitioners in Bulgaria. M Ts, R Jordanova, G Iskrov, R Stefanov Georgian medical news, 16-19, 2011 | 39 | 2011 |
Real-world experiences in autistic adult diagnostic services and post-diagnostic support and alignment with services guidelines: Results from the ASDEU study ML Scattoni, M Micai, A Ciaramella, T Salvitti, F Fulceri, LM Fatta, ... Journal of Autism and Developmental Disorders, 1-18, 2021 | 38 | 2021 |
Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations G Iskrov, R Stefanov Orphan Drugs: Research and Reviews, 1-9, 2014 | 35 | 2014 |
Economic burden and health-related quality of life of patients with cystic fibrosis in Bulgaria GG Iskrov, RS Stefanov, J López-Bastida, R Linertová, J Oliva-Moreno, ... Medical University Plovdiv (Bulgaria), 2015 | 27 | 2015 |
Access to orphan drugs–comparison across Balkan countries AV Pejcic, G Iskrov, MM Jakovljevic, R Stefanov Health Policy 122 (6), 583-589, 2018 | 26 | 2018 |
Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria G Iskrov, R Stefanov Balkan Med J 33 (1), 27-35, 2016 | 23 | 2016 |